Orbotech offers GE nuclear medicine detector-making ability
General Electric Co.’s (NYSE:GE) healthcare unit followed up the announcement last week of its half-billion-dollar acquisition of cancer diagnostic company Clarient Inc. (NASDAQ:CLRT) with a new deal to acquire Orbotech Ltd. (NASDAQ:ORBK) subsidiary Orbotech Medical Solutions Ltd. The $9 million cash deal, with up to $5 million in performance-based add-ons, will expand GE Healthcare’s nuclear […]